KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Gains from Investment Securities (2020 - 2025)

Oscar Health (OSCR) has disclosed Gains from Investment Securities for 6 consecutive years, with $1.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities changed N/A year-over-year to $1.7 million, compared with a TTM value of $4.0 million through Dec 2025, up 498.66%, and an annual FY2025 reading of $4.0 million, up 498.66% over the prior year.
  • Gains from Investment Securities was $1.7 million for Q3 2025 at Oscar Health, down from $2.2 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $2.2 million in Q2 2025 and bottomed at -$2.9 million in Q4 2022.
  • Average Gains from Investment Securities over 5 years is $253875.0, with a median of $116000.0 recorded in 2021.
  • Peak annual rise in Gains from Investment Securities hit 10740.0% in 2022, while the deepest fall reached 783.92% in 2022.
  • Year by year, Gains from Investment Securities stood at $429000.0 in 2021, then crashed by 783.92% to -$2.9 million in 2022, then soared by 63.53% to -$1.1 million in 2023, then soared by 162.99% to $674000.0 in 2024, then surged by 159.05% to $1.7 million in 2025.
  • Business Quant data shows Gains from Investment Securities for OSCR at $1.7 million in Q3 2025, $2.2 million in Q2 2025, and $119000.0 in Q1 2025.